Saskatchewan's provincial stem cell transplant and cellular therapy programme, run by the Saskatchewan Cancer Agency for residents of the province.
The Stem Cell Transplant and Cellular Therapy Programme is run by the Saskatchewan Cancer Agency, the province's cancer service. According to its page, the programme treats people with blood cancers and disorders of the blood and immune system, with the stated aim of lengthening remission or in some cases curing the disease. That aim is the agency's own statement and is not a promise of outcome.
The site describes three treatments. In an autologous transplant, the patient's own stem cells are harvested and frozen, then returned after intensive chemotherapy to help the body recover. In an allogeneic transplant, stem cells from a related or unrelated donor are given after chemotherapy and possibly radiotherapy, with the aim of replacing the patient's immune system.
The third is CAR T-cell therapy. The site explains that the patient's own T-cells are collected, manufactured in a laboratory so that they carry receptors able to detect cancer cells, and returned after chemotherapy. It states clearly that CAR T-cell therapy is currently available only to patients with specific blood cancers or lymphomas.
The programme is limited to Saskatchewan Cancer Agency patients and residents of Saskatchewan, and patients are directed to their health care team or the quality of care coordinator. The agency publishes video presentations and handbooks covering autologous transplant, allogeneic transplant and CAR T-cell therapy, including material on the side effects known as cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. The page does not name individual physicians and says nothing about cost.
The site names the following groups of conditions treated, and notes that CAR T-cell therapy is restricted to certain blood cancers and lymphomas.
The site states that the programme gives stem cell transplants using the patient's own cells or a donor's, and also manufactures modified T-cells from the patient for CAR T-cell therapy.
The programme page does not name individual physicians.
The programme is operated by the Saskatchewan Cancer Agency for the province of Saskatchewan. The page gives a direct telephone number and a toll-free line and directs patients to their health care team or the quality of care coordinator, but does not publish a street address for the transplant unit on this page. Access is limited to Saskatchewan Cancer Agency patients and Saskatchewan residents.
The page says nothing about cost. It is a service of Saskatchewan's publicly funded cancer agency, but the site itself makes no statement about fees.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.